| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 04/11/2002 | US20020042380 Topical application of ascorbic acid compounds for augmenting the synthesis of epidermal ceramides |
| 04/11/2002 | US20020042376 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 04/11/2002 | US20020041976 Novel compounds and their manufacture and use |
| 04/11/2002 | DE10124905A1 Propionsäurederivate Propionic acid derivatives |
| 04/11/2002 | DE10048714A1 5-Amino-1-penlen-3-ol-Derivate 5-amino-1-penlen-3-ol derivatives |
| 04/11/2002 | DE10047295A1 Medicinal use of galiella lactone as specific interleukin-6 signal induction inhibitor e.g. in treatment of fibrotic, cerebrovascular or neurodegenerative disease, pain, inflammation or tumors |
| 04/11/2002 | CA2424925A1 Rare earth or gallium additive composition, methods for preparing same and use thereof as catalyst |
| 04/11/2002 | CA2424870A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | CA2419777A1 Pharmaceutical compounds |
| 04/10/2002 | EP1194426A2 Benzofurane derivatives |
| 04/10/2002 | EP1117482B1 Method for producing catalysts for synthesising maleic anhydride by means of gas phase oxidation |
| 04/10/2002 | EP1112261B1 2-ethyl-2,3-dihydrobenzofuran-carboxylic acid ester derivative, preparation method and use for preparing efaroxan derivatives |
| 04/10/2002 | EP1017688B1 Method for producing phthalides |
| 04/10/2002 | EP0795331B1 Ocular depressor |
| 04/10/2002 | EP0734387B1 Hiv protease inhibitors |
| 04/10/2002 | CN1344265A Piperidine, tetrahydropyridine and piperazine derivatives, their prepn. and use |
| 04/10/2002 | CN1344243A Liquid crystal compounds |
| 04/10/2002 | CN1082390C Method of separating oligomeric side-products from isomerization catalyst |
| 04/10/2002 | CN1082370C Pharmaceutical compsn. contg. 4-oxo-butynic acid |
| 04/10/2002 | CN1082362C Cosmetic preparation comprising photostable UV-A filters |
| 04/09/2002 | US6369243 Acid catalyst |
| 04/09/2002 | US6369226 Substituted benzamide inhibitors of rhinovirus 3C protease |
| 04/09/2002 | US6369102 Glaucoma |
| 04/09/2002 | US6369101 Therapeutic method to treat herpes virus infection |
| 04/09/2002 | US6369072 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 04/09/2002 | US6369069 Cardiovascular disorders |
| 04/09/2002 | US6368389 Method for separating vaporous phthalic acid anhydride from a gas stream |
| 04/04/2002 | WO2002026726A2 Antiviral compositions and methods of use |
| 04/04/2002 | WO2002026725A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-HYDROXY-η-BUTYROLACTONE |
| 04/04/2002 | WO2002026696A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 04/04/2002 | WO2002026227A1 Lactone integrin antagonists |
| 04/04/2002 | WO2002004407A3 7-substituted tetracycline compounds |
| 04/04/2002 | WO2001090097A3 Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them |
| 04/04/2002 | WO2001085694A3 Substituted diamide derivatives useful as motilin antagonists |
| 04/04/2002 | WO2001081332A3 2-fluorobenzenesulfonyl compounds for the treatment of inflammation |
| 04/04/2002 | US20020040154 Reacting arylhydroxy compound and an epoxy compound to form an epoxy-aryl ether; reacting epoxy-aryl ether with active methylene compound to form a lactone; reducing to provide hydroxy-substituted tetrahydrofuran |
| 04/04/2002 | US20020040153 Reductive hydrolysis of 5-(amido)-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)1,3-dihy -droisobenzofuran to form 5-formyl-derivative; converting to citalopram |
| 04/04/2002 | US20020040029 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 04/04/2002 | US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity |
| 04/04/2002 | US20020040003 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus |
| 04/04/2002 | US20020039998 Administering to human therapeutically effective amount of a combination of drug which is metabolized by cytochrome p450 monooxygenase or pharmaceutically acceptable salt thereof and ritonavir |
| 04/04/2002 | CA2423434A1 Lactone integrin antagonists |
| 04/03/2002 | EP1193254A1 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method of using the same |
| 04/03/2002 | EP1193248A1 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
| 04/03/2002 | EP1192145A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 04/03/2002 | EP1192137A1 COMPOUNDS FOR THE MODULATION OF PPAR$g(g) ACTIVITY |
| 04/03/2002 | EP1192128A1 Thiol derivative, metallo-beta-lactamase inhibitors |
| 04/03/2002 | EP1192127A1 Substituted benzamide inhibitors of rhinovirus 3c protease |
| 04/03/2002 | EP0873331B1 Benzofuran carboxamides and sulphonamides |
| 04/03/2002 | EP0868466B1 Soil release polymers with fluorescent whitening properties |
| 04/03/2002 | CN1343207A Benzofuran-2-ones as colorants for organic materials |
| 04/03/2002 | CN1081920C Herba pteridis semipinnatae extract and its medicinal composite |
| 04/02/2002 | US6365747 Method for the preparation of citalopram |
| 04/02/2002 | US6365579 Nitrate esters and their use for neurological conditions |
| 04/02/2002 | US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
| 03/28/2002 | WO2002024674A1 Benzoic acid derivatives and uses thereof |
| 03/28/2002 | WO2002024673A1 Tetrahydrofuran derivatives and their use as nk-1 antagonists |
| 03/28/2002 | WO2002024672A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2002024635A2 Aminoalcohol derivatives |
| 03/28/2002 | WO2002024632A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 03/28/2002 | WO2002024619A1 Amine compounds |
| 03/28/2002 | WO2002024613A2 Resorcinol derivatives |
| 03/28/2002 | WO2001064676A3 INHIBITORS OF p38-α KINASE |
| 03/28/2002 | WO2001007405A3 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 03/28/2002 | US20020038064 For marking a liquid petroluem product, wherein marker develops a color on contact with a developing reagent |
| 03/28/2002 | US20020038040 Process for the preparation of hydroxylactones |
| 03/28/2002 | US20020038033 Treating tetrahydrofuran derivativ with an oxophilic electrophilic reagent in a manner that is effective to provide the oxazoline compound |
| 03/28/2002 | US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes |
| 03/28/2002 | US20020037991 Photosensitive resin composition |
| 03/28/2002 | US20020037918 1-(aryl)-4-methyl-11-(hetrocycle)undeca-4,6,10-trien-1-ol for example; anticancer treatment, inhibit tubulin polymerization, inhibit binding of colchicine to tubulin, antiproliferative agents |
| 03/28/2002 | US20020037900 Hydroxamic acid derivatives |
| 03/28/2002 | US20020037896 Bicyclic compounds |
| 03/28/2002 | US20020037885 Therapeutic compounds |
| 03/28/2002 | US20020037808 Shaped Raney catalyst |
| 03/28/2002 | US20020037578 Inhibiting homoserine lactone (HSL) and/or acylated homoserine lactone (AHL) regulated processes in microorganisms, such as swarming or swimming with a furanone compound; use on pathogens of plants, fish, animals, and crustaceans |
| 03/28/2002 | US20020037349 Flavour precursors |
| 03/28/2002 | US20020037327 Dissociating covalent bonds in an ozonide lesion in an oncogene's TATA box for cancer therapy |
| 03/28/2002 | DE10139115A1 Citalopram enthaltende pharmazeutische Zusammensetzung Citalopram pharmaceutical composition containing |
| 03/28/2002 | DE10045465A1 Verfahren zur atmosphärischen Herstellung von Furfural mit Hilfe eines gasförmigen Katalysators A process for the production of furfural atmospheric by means of a gaseous catalyst |
| 03/28/2002 | CA2423262A1 Resorcinol derivatives |
| 03/28/2002 | CA2421869A1 Tetrahydrofuran derivatives and their use as nk-1 antagonists |
| 03/28/2002 | CA2420185A1 Benzoic acid derivatives and uses thereof |
| 03/28/2002 | CA2416136A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/27/2002 | EP1191611A2 Piezoelectric element and process for production thereof |
| 03/27/2002 | EP1191084A2 Colorless petroleum marker dyes |
| 03/27/2002 | EP1191020A2 Material for organic electroluminescence device and use thereof |
| 03/27/2002 | EP1190079A2 Control of gene expression in eukaryotic cells |
| 03/27/2002 | EP1189879A1 INHIBITORS OF FACTOR Xa |
| 03/27/2002 | EP1189871A1 Aromatic esters for marking or tagging organic products |
| 03/27/2002 | EP1189628A1 Combination of tumor necrosis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/27/2002 | EP0946503B1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 03/27/2002 | EP0934253B1 Halogenalkoximinoacetamide |
| 03/27/2002 | EP0915866B1 Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid |
| 03/27/2002 | EP0873294B1 Production of levulinic acid from carbohydrate-containing materials |
| 03/27/2002 | CN1342156A Inhibition and treatment of hepatitis B virus and flavivirus by helioxanthin and its analogs |
| 03/27/2002 | CN1342153A Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in production of medicaments |
| 03/27/2002 | CN1342137A N2 phenylamidine derivatives |